A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers

NCT00813241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: celecoxib reference formulation
DRUG: celecoxib test formulation A1
DRUG: celecoxib test formulation B2
DRUG: celecoxib test formulation C1

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.